Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of PfSPZ Vaccine Administered by Direct Venous Inoculation: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults

NCT02601716 is registered in ClinicalTrials.gov with Sanaria Inc. as lead sponsor.

NCT NCT02601716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of PfSPZ Vaccine Administered by Direct Venous Inoculation: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults
Lead sponsor
Sanaria Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2016
Completion date
November 30, 2017
Enrollment
92 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria